No important improvement seen in pain, function, quality of life versus placebo surgery, other options
THURSDAY, Feb. 7, 2019 (HealthDay News) — For adults with atraumatic shoulder pain for more than three months diagnosed as subacromial pain syndrome (SAPS), subacromial decompression surgery is not recommended, according to a clinical practice guideline published online Feb. 6 in The BMJ.
To develop guidelines for SAPS, Per Olav Vandvik, M.D., Ph.D., from Lovisenberg Diaconal Hospital in Oslo, Norway, and colleagues used data from two recent high-quality trials of shoulder surgery. The trials examined the benefits and harms of subacromial decompression surgery and the minimally important differences for patient-reported outcome measures.
The researchers note that compared with placebo surgery or other options, surgery did not provide important improvements in pain, function, or quality of life. Surgery was more commonly associated with frozen shoulder.
“The panel concluded that almost all well informed patients would decline surgery and therefore made a strong recommendation against subacromial decompression surgery,” the authors write. “Clinicians should not offer patients subacromial decompression surgery unprompted, and clinicians, public health care providers, and others should make efforts to educate the public regarding the ineffectiveness of surgery.”
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
Early Complications Common in Older Kidney Transplant Recipients
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI
Frailty Linked to Incident Cognitive Decline in Men With CKD
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy